| class name | count | 
|---|---|
| rosids | 1016 | 
| eudicotyledons | 35 | 
| asterids | 23 | 
| Embryophyta | 12 | 
| Spermatophyta | 4 | 
| Magnoliophyta | 3 | 
| class name | count | 
|---|---|
| Fabaceae | 1012 | 
| Berberidaceae | 25 | 
| Orobanchaceae | 16 | 
| Lycopodiaceae | 12 | 
| Cupressaceae | 4 | 
| Daphniphyllaceae | 4 | 
| Convolvulaceae | 4 | 
| Nymphaeaceae | 3 | 
| Viscaceae | 3 | 
| Styracaceae | 3 | 
| Amaranthaceae | 2 | 
| Euphorbiaceae | 1 | 
| Papaveraceae | 1 | 
| Anacardiaceae | 1 | 
| Rosaceae | 1 | 
| Nitrariaceae | 1 | 
 
                  
                | br08003 Category | # of metabolite | 
|---|---|
| Quinolizidine alkaloids | 31 | 
| KNApSAcK ID | name | ChEMBL link | CTD link | # of proteins in ChEMBL interaction / related OMIM / related KEGG DISEASE | # of genes in CTD interaction / related diseases | KCF-S cluster | figure | 
|---|---|---|---|---|---|---|---|
| C00036283   | Dimethamine | No. 85 |   | ||||
| C00032558   | 11,12-Seco-12,13-didehydromultiflorine | C058266 | No. 85 |   | |||
| C00007720   | N-Acetylcytisine | CHEMBL1513538 CHEMBL1553838 | 2 / 3 / 7 | No. 85 |   | ||
| C00026327   | Cernuine | No. 85 |   | ||||
| C00007718   | (-)-N-(N-Acetylaminomethyl)cytisine | No. 85 |   | ||||
| C00007717   | Sophorasine B | No. 85 |   | ||||
| C00026323   | 4beta-Hydroxyepilupinine | No. 85 |   | ||||
| C00002209   | Dehydrolupanine | CHEMBL459396 CHEMBL520093 CHEMBL2008918 | No. 85 |   | |||
| C00026317   | (+/-)-Epilupinine | CHEMBL459397 CHEMBL1435718 | 1 / 1 / 1 | No. 85 |   | ||
| C00026314   | 2,3-Dehydro-O-(2-pyrrolylcarbonyl)virgiline | No. 85 |   | ||||
| C00026313   | O-(2-Pyrrolylcarbonyl)-virgiline | No. 85 |   | ||||
| C00002213   | (-)-Camoensidine | No. 85 |   | ||||
| C00026312   | Calpaurine | No. 85 |   | ||||
| C00026311   | Calpurnine / Oroboidine | C013362 | 0 / 3 | No. 85 |   | ||
| C00007716   | Sophorasine A | No. 85 |   | ||||
| C00026309   | Sessilifoline | No. 85 |   | ||||
| C00007714   | N-(3-Oxobutyl)cytisine | CHEMBL190851 | 4 / 3 / 1 | No. 85 |   | ||
| C00026308   | Digittine / 4beta-Hydroxycalpurnine / 4beta-Hydroxy-13alpha-O-(2'-pyrrolylcarbonyl)lupanine | No. 85 |   | ||||
| C00026301   | Cinegalline | No. 85 |   | ||||
| C00002221   | 13alpha-(Tigloyloxy)lupanine | No. 85 |   | ||||
| C00026291   | 5,6-Dehydroisolupanine | No. 85 |   | ||||
| C00026289   | Multiflorine N-oxide | No. 85 |   | ||||
| C00002225   | d-Sophoridine / (+)-Sophoridine | CHEMBL204860 CHEMBL383443 CHEMBL525227 CHEMBL1396816 CHEMBL1733145 CHEMBL1824581 | 5 / 3 / 7 | No. 85 |   | ||
| C00026287   | Sophocarpine N-oxide / (+)-Sophocarpine N-oxide | CHEMBL380410 | C046246 | No. 85 |   | ||
| C00002227   | (+)-Darvasamine | CHEMBL204860 CHEMBL383443 CHEMBL525227 CHEMBL1396816 CHEMBL1733145 CHEMBL1824581 | 5 / 3 / 7 | No. 85 |   | ||
| C00026286   | (+)-Sophoranol N-oxide | No. 85 |   | ||||
| C00002229   | 9alpha-Hydroxymatrine / (+)-9alpha-Hydroxymatrine | CHEMBL204747 | No. 85 |   | |||
| C00026284   | Camoensidine N-oxide | No. 85 |   | ||||
| C00007713   | (-)-N-(3-Oxobutyl)cytisine | CHEMBL190851 | 4 / 3 / 1 | No. 85 |   | ||
| C00026280   | Oxymatrine / Ammothamnine / Matrine N-oxide / (+)-Matrine N-oxide / Matrine 1beta-oxide | CHEMBL458337 CHEMBL1358502 | C037573 | 3 / 11 / 6 | 0 / 4 | No. 85 |   | 
| C00007712   | Rhombifoline / (-)-Rhombifoline | CHEMBL1397610 | C119591 | No. 85 |   | ||
| C00007704   | Cytisine / (-)-Cytisine | CHEMBL47039 CHEMBL497939 CHEMBL1628606 | C004712 | 27 / 36 / 33 | 6 / 1 | No. 85 |   | 
| C00026268   | N-(Methoxycarbonyl)angustifoline | No. 85 |   | ||||
| C00026267   | N-Formylangustifoline | No. 85 |   | ||||
| C00026264   | Isoangustifoline | CHEMBL459206 | No. 85 |   | |||
| C00026263   | Dehydroretamine | No. 85 |   | ||||
| C00023313   | 5,6-Dehydro-alpha-isolupanine | No. 85 |   | ||||
| C00007781   | 2(S)-Hydroxyaphyllidine | No. 85 |   | ||||
| C00007765   | Multiflorine / (-)-Multiflorine | CHEMBL517095 | No. 85 |   | |||
| C00007764   | (-)-13alpha-Hydroxy-4-oxosparteine | No. 85 |   | ||||
| C00007762   | Leontiformine | CHEMBL1476333 | 2 / 3 / 7 | No. 85 |   | ||
| C00007761   | Schoberine | No. 85 |   | ||||
| C00007757   | 10alpha-Hydroxymethylsparteine | No. 85 |   | ||||
| C00007691   | Cadiamine | No. 85 |   | ||||
| C00007692   | 5alpha-Hydroxysophocarpine | No. 85 |   | ||||
| C00007744   | 11alpha-Allylcytisine | No. 85 |   | ||||
| C00007694   | 4beta,13alpha-Dihydroxyupanine | No. 85 |   | ||||
| C00007701   | Dehydrocytisine B / (-)-Dehydrocytisine B | CHEMBL47039 CHEMBL497939 CHEMBL1628606 | 27 / 36 / 33 | No. 85 |   | ||
| C00007698   | Dehydrocytisine A / (-)-Dehydrocytisine A | CHEMBL47039 CHEMBL497939 CHEMBL1628606 | 27 / 36 / 33 | No. 85 |   | ||
| C00007738   | 7alpha-Hydroxysophoramine | No. 376 |   | ||||
| C00007742   | Isotinctorine | No. 376 |   | ||||
| C00007725   | Baptifoline / (-)-Baptifoline | C106940 | No. 376 |   | |||
| C00007737   | Sophoramine | C055681 | No. 376 |   | |||
| C00007736   | 5,6-Dehydromultiflorine | No. 376 |   | ||||
| C00007735   | Thermopsine / (-)-Thermopsine | CHEMBL203399 CHEMBL509692 CHEMBL1324708 CHEMBL1454284 | C059560 | 7 / 8 / 11 | No. 376 |   | |
| C00026276   | (-)-Sophoridine N-oxide | CHEMBL458337 CHEMBL1358502 | 3 / 11 / 6 | No. 376 |   | ||
| C00002234   | (+)-14alpha-Hydroxymatrine | No. 376 |   | ||||
| C00002218   | 13-Oxolupanine / 13-Ketolupanine / 2,13-Dioxosparteine | No. 376 |   | ||||
| C00002216   | Virgiline | No. 376 |   | ||||
| C00026325   | Anhydrolycocernuine | No. 376 |   | ||||
| C00026326   | Carolinianine | No. 376 |   | ||||
| C00007728   | (-)-Argentamine / (-)-13-Hydroxythermopsine | No. 376 |   | ||||
| C00026339   | (+)-Epilamprolobine N-oxide | No. 376 |   | ||||
| C00007727   | Epibaptifoline / (-)-Epibaptifoline | No. 376 |   | ||||
| C00007726   | 13beta-Hydroxythermopsine | No. 376 |   | ||||
| C00026275   | Deoxoangustifoline | No. 376 |   | ||||
| C00007724   | Dehydrobaptifoline | No. 384 |   | ||||
| C00007723   | Ethyl 12-cytisineacetate | No. 384 |   | ||||
| C00007722   | N-Carbomethoxycytisine / 12-Carboxycytisine methyl ester | No. 384 |   | ||||
| C00023310   | (+)-5,6-Dehydrolupanine | No. 384 |   | ||||
| C00026337   | 9beta-Hydroxylamprolobine | No. 384 |   | ||||
| C00007729   | (-)-9alpha-Hydroxysophoramine | No. 384 |   | ||||
| C00025370   | 5,6-Dehydro-alpha-isosparteine | No. 384 |   | ||||
| C00002207   | 4-Hydroxylupanine | No. 384 |   | ||||
| C00026324   | Epilupinine acetate | No. 384 |   | ||||
| C00026320   | Tashiromine | No. 384 |   | ||||
| C00026319   | (-)-Lupinine | CHEMBL459397 CHEMBL1435718 | C015971 | 1 / 1 / 1 | No. 384 |   | |
| C00002212   | Lupanine / (+)-Lupanine | CHEMBL459396 CHEMBL520093 CHEMBL2008918 | C008298 | No. 384 |   | ||
| C00002215   | 3alpha-Hydroxylupanine | CHEMBL515231 | No. 384 |   | |||
| C00002239   | Dehydroaphylline | CHEMBL509343 | No. 384 |   | |||
| C00007750   | Retamine | No. 384 |   | ||||
| C00026270   | Virgiboidine | No. 384 |   | ||||
| C00026271   | Tetrahydrorhombifoline | CHEMBL460224 | No. 384 |   | |||
| C00002235   | 14b-Hydroxymatrine / (-)-14beta-Hydroxymatrine | No. 384 |   | ||||
| C00002238   | Epiaphylline / Dihydromonspessulanine / 0-Oxo-alpha-isosparteine / 17-Oxo-alpha-isosparteine | CHEMBL509343 | No. 384 |   | |||
| C00007693   | 3beta,13alpha-Dihydroxylupanine | No. 424 |   | ||||
| C00002236   | 14beta-Hydroxymatrine / (-)-14beta-Hydroxymatrine | No. 424 |   | ||||
| C00002233   | (-)-14beta-Hydroxysophoridine | No. 424 |   | ||||
| C00002228   | (+)-Albertamine | CHEMBL1672133 | No. 424 |   | |||
| C00026269   | N-(Ethoxycarbonyl)angustifoline | No. 424 |   | ||||
| C00002224   | Sophoridine / (-)-Sophoridine | CHEMBL204860 CHEMBL383443 CHEMBL525227 CHEMBL1396816 CHEMBL1733145 CHEMBL1824581 | 5 / 3 / 7 | No. 424 |   | ||
| C00026302   | 13alpha-Cinnamoyloxylupanine | No. 424 |   | ||||
| C00007752   | beta-Isosparteine | CHEMBL412873 CHEMBL44625 CHEMBL172633 CHEMBL1328708 CHEMBL1492771 CHEMBL1740920 CHEMBL1908847 CHEMBL2010478 | 93 / 50 / 48 | No. 424 |   | ||
| C00026265   | Angustifoline | CHEMBL459206 | C101930 | No. 424 |   | ||
| C00007681   | 17-Oxosparteine | CHEMBL509343 | C035707 | No. 424 |   | ||
| C00007685   | 6beta-Hydroxylupanine | No. 424 |   | ||||
| C00026260   | 11,12-Dehydrosparteine | No. 424 |   | ||||
| C00026329   | Dihydrodeoxycernuine | No. 424 |   | ||||
| C00007684   | (-)-6alpha-Hydroxylupanine | No. 424 |   | ||||
| C00028974   | Griffithine | No. 424 |   | ||||
| C00007687   | (-)-6alpha-methoxylupanine | No. 424 |   | ||||
| C00007686   | (+)-Darvasoline | No. 424 |   | ||||
| C00007682   | Aphylline | CHEMBL509343 | No. 424 |   | |||
| C00026328   | Lycocernuine | No. 555 |   | ||||
| C00032562   | Deoxynupharidine | CHEMBL140239 CHEMBL140758 | C010908 | No. 555 |   | ||
| C00007743   | Tinctorine / (-)-Tinctorine | No. 555 |   | ||||
| C00026330   | (-)-Epilamprolobine | No. 555 |   | ||||
| C00026306   | 13alpha-Benzoyloxylupanine | No. 555 |   | ||||
| C00007688   | Sophoranol | No. 555 |   | ||||
| C00007689   | 5alpha,9alpha-Dihydroxymatrine | No. 555 |   | ||||
| C00002219   | O-Methyljamaidine / 13-Epimethoxylupanine / 13-epi-Methoxylupanine / 13beta-Methoxylupanine / O-Methyl-13-epihydroxylupanine | No. 555 |   | ||||
| C00025365   | 11,12-Dehydrolupanine / 1,12-Didehydrolupanine | No. 555 |   | ||||
| C00007696   | 3beta,4alpha,13alpha-Trihydroxylupanine | No. 555 |   | ||||
| C00007747   | Thermopsamine / (+)-Thermopsamine | No. 555 |   | ||||
| C00007748   | 13-Hydroxysparteine | No. 555 |   | ||||
| C00007749   | 14alpha-Hydroxysparteine | No. 555 |   | ||||
| C00002211   | (-)-Lupanine | CHEMBL459396 CHEMBL520093 CHEMBL2008918 | No. 555 |   | |||
| C00007690   | Pohakuline / (-)-Pohakuline | No. 555 |   | ||||
| C00007756   | Dehydrosparteine / (-)-Dehydrosparteine | CHEMBL412873 CHEMBL44625 CHEMBL172633 CHEMBL1328708 CHEMBL1492771 CHEMBL1740920 CHEMBL1908847 CHEMBL2010478 | 93 / 50 / 48 | No. 1023 |   | ||
| C00007740   | O-Acetylbaptifolin | No. 1023 |   | ||||
| C00007739   | Acetylepibaptifoline / O-Acetylepibaptifoline | No. 1023 |   | ||||
| C00007741   | (-)-Clathrotropine | No. 1023 |   | ||||
| C00007730   | Leontidine | No. 1023 |   | ||||
| C00002208   | Nuttalline / 7-Hydroxylupanine / 4-beta-Hydroxylupanine | C035706 | No. 1023 |   | |||
| C00007734   | Anagyrine / (-)-Anagyrine | CHEMBL203399 CHEMBL509692 CHEMBL1324708 CHEMBL1454284 | C012736 | 7 / 8 / 11 | No. 1023 |   | |
| C00007732   | Camoensine | No. 1023 |   | ||||
| C00026334   | Lamprolobine | No. 1023 |   | ||||
| C00023307   | Aphyllidine | No. 1211 |   | ||||
| C00007782   | (-)-Argyrolobine / 2-(R)-Hydroxyaphyllidine | No. 1211 |   | ||||
| C00007760   | 7-Hydroxysparteine | No. 1211 |   | ||||
| C00007695   | 3beta,4alpha-Dihydroxy-13beta-methoxylupanine | No. 1211 |   | ||||
| C00007751   | Spartein / (-)-Spartein | CHEMBL412873 CHEMBL44625 CHEMBL172633 CHEMBL1328708 CHEMBL1492771 CHEMBL1740920 CHEMBL1908847 CHEMBL2010478 | D013034 | 93 / 50 / 48 | 1 / 2 | No. 1211 |   | 
| C00007758   | 7-Hydroxypusilline / (-)-7-Hydroxy-beta-isosparteine | No. 1211 |   | ||||
| C00026318   | (+)-Epilupinine | CHEMBL459397 CHEMBL1435718 | 1 / 1 / 1 | No. 1211 |   | ||
| C00026281   | Lupanine N-oxide | No. 1211 |   | ||||
| C00025362   | 5,6-Dehydrolupanine | No. 1268 |   | ||||
| C00007705   | 12-Hydroxycytisine | No. 1268 |   | ||||
| C00007709   | Caulophylline / N-Methylcytisine / (-)-N-Methylcytisine | CHEMBL66191 CHEMBL1085045 | C034245 | No. 1268 |   | ||
| C00007707   | N-Formylcytisine / (-)-N-Formylcytisine | CHEMBL1396784 CHEMBL1433686 | 4 / 6 / 11 | No. 1268 |   | ||
| C00002217   | Calpurmenine | No. 1268 |   | ||||
| C00007746   | 13-Epihydroxysparteine / 13beta-Hydroxysparteine / 13-Epi-hydroxysparteine | No. 1636 |   | ||||
| C00007745   | Deoxonuttaline / 4alpha-Hydroxysparteine / (-)-4alpha-Hydroxysparteine | No. 1636 |   | ||||
| C00007721   | Ethyl cytisine-12-carboxylate / 12-Carboxycytisine ethyl ester | No. 1636 |   | ||||
| C00007719   | 12-Cytisineacetamide | CHEMBL508431 | No. 1636 |   | |||
| C00002214   | Camoensidine | No. 1636 |   | ||||
| C00025367   | (2R,9R)-Dihydroxyaphyllidine | No. 1636 |   | ||||
| C00007779   | Argyrolobine / 2(R)-Hydroxyaphyllidine | No. 1838 |   | ||||
| C00025366   | (2S,9R)-Dihydroxyaphyllidine | No. 1838 |   | ||||
| C00026303   | 13alpha-(Cinnamoyloxy)-lupanine | No. 1838 |   | ||||
| C00002226   | Matrine / (+)-Matrine | CHEMBL204860 CHEMBL383443 CHEMBL525227 CHEMBL1396816 CHEMBL1733145 CHEMBL1824581 | C034244 | 5 / 3 / 7 | 4 / 5 | No. 1838 |   | 
| C00025369   | 5,6-Dehydrosparteine | C044693 | No. 1838 |   | |||
| C00007678   | Deoxylupanoline / Anhydrodihydrolupanoline / 10-Oxo-beta-isosparteine / 17-Oxo-beta-isosparteine | CHEMBL509343 | No. 1838 |   | |||
| C00028194   | Argentine | No. 2032 |   | ||||
| C00001943   | 13-Hydroxylupanine / (+)-13-Hydroxylupanine / (+)-13alpha-Hydroxylupanine | CHEMBL518007 | C091205 | No. 2032 |   | ||
| C00001935   | 13beta-Hydroxylupanine | CHEMBL518007 | No. 2032 |   | |||
| C00027863   | (-)-12,12'-Methylenedicytisine | No. 2032 |   | ||||
| C00001934   | 13alpha-Hydroxyisolupanine / 13-Hydroxy-alpha-isolupanine | CHEMBL518007 | No. 2032 |   | |||
| C00026292   | Cinevanine | No. 2957 |   | ||||
| C00007775   | 13alpha-Hydroxymultiflorine | No. 2957 |   | ||||
| C00002223   | Allmatrine / 6-Allomatrine / 6beta-Matrine / (+)-Allomatrine / Tetrahydroisosophoramine | CHEMBL204860 CHEMBL383443 CHEMBL525227 CHEMBL1396816 CHEMBL1733145 CHEMBL1824581 | 5 / 3 / 7 | No. 2957 |   | ||
| C00026272   | 11-Oxotetrahydrorhombifoline | No. 2957 |   | ||||
| C00032557   | Albine | CHEMBL514884 | No. 3172 |   | |||
| C00002210   | alpha-Isolupanine | CHEMBL459396 CHEMBL520093 CHEMBL2008918 | No. 3172 |   | |||
| C00007784   | Epiaphyllidine / 11-Epiaphyllidine | No. 3172 |   | ||||
| C00002204   | Chamaetine / Epinuttaline / (+)-Chamaetine | No. 5313 |   | ||||
| C00007754   | alpha-Isosparteine | CHEMBL412873 CHEMBL44625 CHEMBL172633 CHEMBL1328708 CHEMBL1492771 CHEMBL1740920 CHEMBL1908847 CHEMBL2010478 | 93 / 50 / 48 | No. 5313 |   | ||
| C00001971   | 3-Hydroxylupanine | No. 6163 |   | ||||
| C00002220   | 13alpha-Methoxylupanine | No. 6875 |   | 
| accession | description | class description | KNApSAcK metabolite in interactions | # of diseases (OMIM / KEGG) | 
|---|---|---|---|---|
| Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00002207 C00002218 C00002224 C00002227 C00002236 C00002238 C00007681 C00007682 C00007735 C00007736 C00007757 C00023313 C00026289 C00026301 C00026325 C00026326 C00026329 | 1 / 2 | 
| O00255 | Menin | Unclassified protein | C00002207 C00002218 C00002224 C00002227 C00002236 C00002238 C00007681 C00007682 C00007735 C00007736 C00007757 C00023313 C00026289 C00026301 C00026325 C00026326 C00026329 | 2 / 5 | 
| P28482 | Mitogen-activated protein kinase 1 | Erk | C00002227 C00002236 C00007681 C00007682 C00007757 C00023313 C00026289 C00026301 C00026329 | 0 / 0 | 
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00002207 C00002218 C00002236 C00002238 C00007681 C00007682 C00026325 C00026326 C00026329 | 1 / 0 | 
| Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00002227 C00002236 C00007681 C00007682 C00007757 C00023313 C00026289 C00026301 C00026329 | 0 / 0 | 
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00002207 C00002218 C00002236 C00002238 C00007681 C00007682 C00026325 C00026326 C00026329 | 1 / 1 | 
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00002218 C00002236 C00007681 C00007682 C00007735 C00026325 C00026326 C00026329 | 0 / 1 | 
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00002218 C00002236 C00007681 C00007682 C00026325 C00026326 C00026329 | 0 / 0 | 
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00002218 C00002236 C00007681 C00007682 C00026325 C00026326 C00026329 | 0 / 1 | 
| P02545 | Prelamin-A/C | Unclassified protein | C00002218 C00002236 C00007681 C00007682 C00026325 C00026326 C00026329 | 11 / 10 | 
| P83916 | Chromobox protein homolog 1 | Unclassified protein | C00002218 C00007758 C00026281 C00026325 C00026326 | 0 / 0 | 
| P11387 | DNA topoisomerase 1 | Isomerase | C00002227 C00007757 C00023313 C00026289 C00026301 | 0 / 0 | 
| P10636 | Microtubule-associated protein tau | Unclassified protein | C00002218 C00007758 C00026281 C00026325 C00026326 | 4 / 3 | 
| P43681 | Neuronal acetylcholine receptor subunit alpha-4 | CHRN alpha | C00002218 C00026275 C00026325 C00026326 C00026339 | 1 / 1 | 
| B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00002207 C00002218 C00002238 C00026325 C00026326 | 0 / 0 | 
| P32297 | Neuronal acetylcholine receptor subunit alpha-3 | CHRN alpha | C00002218 C00026275 C00026325 C00026326 C00026339 | 1 / 0 | 
| P30926 | Neuronal acetylcholine receptor subunit beta-4 | CHRN beta | C00002218 C00026275 C00026325 C00026326 C00026339 | 0 / 0 | 
| P17787 | Neuronal acetylcholine receptor subunit beta-2 | CHRN beta | C00002218 C00026275 C00026325 C00026326 C00026339 | 1 / 1 | 
| P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00002236 C00007681 C00007682 C00026329 | 5 / 9 | 
| P35367 | Histamine H1 receptor | Histamine receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00002236 C00007681 C00007682 C00026329 | 1 / 0 | 
| P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P06241 | Tyrosine-protein kinase Fyn | Src | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00002236 C00007681 C00007682 C00026329 | 1 / 1 | 
| P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 1 | 
| P00918 | Carbonic anhydrase 2 | Lyase | C00002236 C00007681 C00007682 C00026329 | 1 / 2 | 
| P33765 | Adenosine receptor A3 | Adenosine receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P14780 | Matrix metalloproteinase-9 | M10A | C00002236 C00007681 C00007682 C00026329 | 2 / 2 | 
| P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P27361 | Mitogen-activated protein kinase 3 | Erk | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P06239 | Tyrosine-protein kinase Lck | Src | C00002236 C00007681 C00007682 C00026329 | 0 / 1 | 
| P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00002236 C00007681 C00007682 C00026329 | 1 / 1 | 
| P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00002236 C00007681 C00007682 C00026329 | 1 / 8 | 
| P17252 | Protein kinase C alpha type | Alpha | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P14416 | D(2) dopamine receptor | Dopamine receptor | C00002236 C00007681 C00007682 C00026329 | 2 / 0 | 
| P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P41145 | Kappa-type opioid receptor | Opioid receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P29274 | Adenosine receptor A2a | Adenosine receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00002236 C00007681 C00007682 C00026329 | 1 / 1 | 
| P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00002236 C00007681 C00007682 C00026329 | 1 / 0 | 
| P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00002236 C00007681 C00007682 C00026329 | 2 / 2 | 
| P30542 | Adenosine receptor A1 | Adenosine receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P21917 | D(4) dopamine receptor | Dopamine receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P30988 | Calcitonin receptor | Calcitonin receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P35462 | D(3) dopamine receptor | Dopamine receptor | C00002236 C00007681 C00007682 C00026329 | 1 / 0 | 
| P41143 | Delta-type opioid receptor | Opioid receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P29466 | Caspase-1 | C14 | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P25101 | Endothelin-1 receptor | Endothelin receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P30411 | B2 bradykinin receptor | Bradykinin receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00002236 C00007681 C00007682 C00026329 | 1 / 0 | 
| P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P08311 | Cathepsin G | S1A | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00002236 C00007681 C00007682 C00026329 | 1 / 0 | 
| P03956 | Interstitial collagenase | M10A | C00002236 C00007681 C00007682 C00026329 | 0 / 1 | 
| P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P08246 | Neutrophil elastase | S1A | C00002236 C00007681 C00007682 C00026329 | 2 / 1 | 
| P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00002236 C00007681 C00007682 C00026329 | 1 / 1 | 
| P04150 | Glucocorticoid receptor | NR3C1 | C00002236 C00007681 C00007682 C00026329 | 0 / 1 | 
| P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00002236 C00007681 C00007682 C00026329 | 2 / 0 | 
| P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00002236 C00007681 C00007682 C00026329 | 0 / 3 | 
| P25021 | Histamine H2 receptor | Histamine receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00002236 C00007681 C00007682 C00026329 | 1 / 0 | 
| P21452 | Substance-K receptor | Neurokinin receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00002236 C00007681 C00007682 C00026329 | 3 / 0 | 
| P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00002236 C00007681 C00007682 C00026329 | 1 / 0 | 
| P21728 | D(1A) dopamine receptor | Dopamine receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00002236 C00007681 C00007682 C00026329 | 2 / 1 | 
| Q16539 | Mitogen-activated protein kinase 14 | p38 | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P03372 | Estrogen receptor | NR3A1 | C00002236 C00007681 C00007682 C00026329 | 1 / 1 | 
| P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00002236 C00007681 C00007682 C00026329 | 1 / 0 | 
| P22303 | Acetylcholinesterase | Hydrolase | C00002236 C00007681 C00007682 C00026329 | 1 / 0 | 
| P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P35372 | Mu-type opioid receptor | Opioid receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P25103 | Substance-P receptor | Neurokinin receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P25105 | Platelet-activating factor receptor | PAF receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 | 
| P31645 | Sodium-dependent serotonin transporter | Serotonin | C00002236 C00007681 C00007682 C00026329 | 2 / 0 | 
| Q92731 | Estrogen receptor beta | NR3A2 | C00002236 C00007681 C00007682 C00026329 | 0 / 1 | 
| Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00002207 C00002238 C00007735 | 3 / 3 | 
| P36544 | Neuronal acetylcholine receptor subunit alpha-7 | CHRN alpha | C00002218 C00026325 C00026326 | 0 / 0 | 
| O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00002218 C00026325 C00026326 | 0 / 0 | 
| Q15822 | Neuronal acetylcholine receptor subunit alpha-2 | CHRN alpha | C00002218 C00026325 C00026326 | 1 / 1 | 
| O75496 | Geminin | Unclassified protein | C00002218 C00026325 C00026326 | 0 / 0 | 
| Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00002218 C00026325 C00026326 | 1 / 4 | 
| P11230 | Acetylcholine receptor subunit beta | CHRN beta | C00002218 C00026325 C00026326 | 2 / 1 | 
| P02708 | Acetylcholine receptor subunit alpha | CHRN alpha | C00002218 C00026325 C00026326 | 3 / 2 | 
| Q13951 | Core-binding factor subunit beta | Unclassified protein | C00002218 C00026325 C00026326 | 0 / 1 | 
| Q07001 | Acetylcholine receptor subunit delta | CHRN delta | C00002218 C00026325 C00026326 | 3 / 2 | 
| Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00002226 C00007678 C00026303 | 1 / 1 | 
| P04062 | Glucosylceramidase | Enzyme | C00002218 C00026325 C00026326 | 6 / 4 | 
| Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00002218 C00026325 C00026326 | 0 / 0 | 
| P07510 | Acetylcholine receptor subunit gamma | CHRN gamma | C00002218 C00026325 C00026326 | 2 / 1 | 
| P00352 | Retinal dehydrogenase 1 | Enzyme | C00002207 C00002238 | 0 / 0 | 
| P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00007758 C00026281 | 7 / 3 | 
| gene | gene name | gene description | KNApSAcK metabolite in interactions | 
|---|---|---|---|
| 1135 | CHRNA2 | cholinergic receptor, nicotinic, alpha 2 (neuronal) | C00002218 | 
| 1136 | CHRNA3, LNCR2, NACHRA3, PAOD2 | cholinergic receptor, nicotinic, alpha 3 (neuronal) | C00002218 | 
| 1137 | CHRNA4, BFNC, EBN, EBN1, NACHR, NACHRA4, NACRA4 | cholinergic receptor, nicotinic, alpha 4 (neuronal) | C00002218 | 
| 1139 | CHRNA7, CHRNA7-2, NACHRA7 | cholinergic receptor, nicotinic, alpha 7 (neuronal) | C00002218 | 
| 1141 | CHRNB2, EFNL3, nAChRB2 | cholinergic receptor, nicotinic, beta 2 (neuronal) | C00002218 | 
| 1143 | CHRNB4 | cholinergic receptor, nicotinic, beta 4 (neuronal) | C00002218 | 
| 4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog | C00002227 | 
| 4893 | NRAS, ALPS4, N-ras, NRAS1, NS6 | neuroblastoma RAS viral (v-ras) oncogene homolog | C00002227 | 
| 7150 | TOP1, TOPI | topoisomerase (DNA) I (EC:5.99.1.2) | C00002227 | 
| 7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 | C00002227 | 
| 1565 | CYP2D6, CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, CYPIID6, P450-DB1, P450C2D, P450DB1 | cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) | C00002236 | 
| OMIM | preferred title | UniProt | 
|---|---|---|
| #300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency | Q99714 | 
| #100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism | P20309 | 
| #219080 | Acth-independent macronodular adrenal hyperplasia; aimah | P63092 | 
| #103780 | Alcohol dependence | P08172 P14416 P31645 | 
| #614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 | Q99720 | 
| #602025 | Body mass index quantitative trait locus 9; bmiq9 | P41968 | 
| #300615 | Brunner syndrome | P21397 | 
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a | P02545 | 
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism | P02545 | 
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 | P02545 | 
| #162800 | Cyclic neutropenia | P08246 | 
| #612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 | P51681 | 
| #609535 | Drug metabolism, poor, cyp2c19-related | P33261 | 
| #608902 | Drug metabolism, poor, cyp2d6-related | P10635 | 
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 | P02545 | 
| #600513 | Epilepsy, nocturnal frontal lobe, 1; enfl1 | P43681 | 
| #605375 | Epilepsy, nocturnal frontal lobe, 3; enfl3 | P17787 | 
| #610353 | Epilepsy, nocturnal frontal lobe, 4; enfl4 | Q15822 | 
| #615363 | Estrogen resistance; estrr | P03372 | 
| #600274 | Frontotemporal dementia; ftd | P10636 | 
| #613659 | Gastric cancer | P04626 | 
| #137215 | Gastric cancer, hereditary diffuse; hdgc | P04626 | 
| #608013 | Gaucher disease, perinatal lethal | P04062 | 
| #230800 | Gaucher disease, type i | P04062 | 
| #230900 | Gaucher disease, type ii | P04062 | 
| #231000 | Gaucher disease, type iii | P04062 | 
| #231005 | Gaucher disease, type iiic | P04062 | 
| #231095 | Ghosal hematodiaphyseal dysplasia; ghdd | P24557 | 
| #137800 | Glioma susceptibility 1; glm1 | P04626 | 
| #605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay | Q03164 | 
| #610140 | Heart-hand syndrome, slovenian type | P02545 | 
| #609423 | Human immunodeficiency virus type 1, susceptibility to | P41597 P51681 | 
| #176670 | Hutchinson-gilford progeria syndrome; hgps | P02545 | 
| #145000 | Hyperparathyroidism 1; hrpt1 | O00255 | 
| #603932 | Intervertebral disc disease; idd | P14780 | 
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 | P02545 | 
| #613688 | Long qt syndrome 2; lqt2 | Q12809 | 
| #211980 | Lung cancer | P00533 P04626 | 
| #608516 | Major depressive disorder; mdd | P08172 | 
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada | P02545 | 
| #174800 | Mccune-albright syndrome; mas | P63092 | 
| #300705 | Mental retardation, x-linked 17; mrx17 | Q99714 | 
| %300852 | Mental retardation, x-linked 88; mrx88 | P50052 | 
| #300220 | Mental retardation, x-linked, syndromic 10; mrxs10 | Q99714 | 
| #613073 | Metaphyseal anadysplasia 2; mandp2 | P14780 | 
| #131100 | Multiple endocrine neoplasia, type i; men1 | O00255 | 
| #265000 | Multiple pterygium syndrome, escobar variant; evmps | P07510 | 
| #253290 | Multiple pterygium syndrome, lethal type; lmps | P02708 P07510 Q07001 | 
| #126200 | Multiple sclerosis, susceptibility to; ms | P08575 | 
| #613205 | Muscular dystrophy, congenital, lmna-related | P02545 | 
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b | P02545 | 
| #608931 | Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency | P11230 | 
| #608930 | Myasthenic syndrome, congenital, fast-channel | P02708 Q07001 | 
| #601462 | Myasthenic syndrome, congenital, slow-channel; sccms | P02708 P11230 Q07001 | 
| #159900 | Myoclonic dystonia | P14416 | 
| #202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 | P08246 | 
| #601665 | Obesity | P32245 | 
| #164230 | Obsessive-compulsive disorder; ocd | P31645 | 
| #604715 | Orthostatic intolerance | P23975 | 
| #166350 | Osseous heteroplasia, progressive; poh | P63092 | 
| #259730 | Osteopetrosis, autosomal recessive 3; optb3 | P00918 | 
| #167000 | Ovarian cancer | P04626 | 
| #168600 | Parkinson disease, late-onset; pd | P04062 | 
| #260540 | Parkinson-dementia syndrome | P10636 | 
| #613135 | Parkinsonism-dystonia, infantile; pkdys | Q01959 | 
| #172700 | Pick disease of brain | P10636 | 
| #102200 | Pituitary adenoma, growth hormone-secreting | P63092 | 
| #601399 | Platelet disorder, familial, with associated myeloid malignancy | Q01196 | 
| #103580 | Pseudohypoparathyroidism, type ia; php1a | P63092 | 
| #603233 | Pseudohypoparathyroidism, type ib; php1b | P63092 | 
| #612462 | Pseudohypoparathyroidism, type ic; php1c | P63092 | 
| #607276 | Resting heart rate, variation in | P08588 | 
| #275210 | Restrictive dermopathy, lethal | P02545 | 
| #608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive | P08575 | 
| #609620 | Short qt syndrome 1; sqt1 | Q12809 | 
| #612052 | Smoking as a quantitative trait locus 3; sqtl3 | P32297 | 
| #607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 | Q9NUW8 | 
| #601104 | Supranuclear palsy, progressive, 1; psnp1 | P10636 | 
| #190300 | Tremor, hereditary essential, 1; etm1 | P35462 | 
| #610379 | West nile virus, susceptibility to | P51681 | 
| #112100 | Yt blood group antigen | P22303 | 
| KEGG | name | UniProt | 
|---|---|---|
| H00033 | Adrenal carcinoma | O00255
                            (related) | 
| H00034 | Carcinoid | O00255
                            (related) | 
| H00045 | Malignant islet cell carcinoma | O00255
                            (related) | 
| H00246 | Primary hyperparathyroidism | O00255
                            (related) | 
| H01102 | Pituitary adenomas | O00255
                            (related) | 
| H00016 | Oral cancer | P00533
                            (related) P00533 (marker) | 
| H00017 | Esophageal cancer | P00533
                            (related) P35354 (related) | 
| H00018 | Gastric cancer | P00533
                            (related) P04626 (related) | 
| H00022 | Bladder cancer | P00533
                            (related) P04626 (related) | 
| H00028 | Choriocarcinoma | P00533
                            (related) P03956 (related) P04626 (related) | 
| H00030 | Cervical cancer | P00533
                            (related) P04626 (related) | 
| H00042 | Glioma | P00533
                            (related) P00533 (marker) | 
| H00055 | Laryngeal cancer | P00533
                            (related) P00533 (marker) | 
| H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) | P00918
                            (related) | 
| H00436 | Osteopetrosis | P00918
                            (related) | 
| H00264 | Charcot-Marie-Tooth disease (CMT) | P02545
                            (related) | 
| H00294 | Dilated cardiomyopathy (DCM) | P02545
                            (related) | 
| H00420 | Familial partial lipodystrophy (FPL) | P02545
                            (related) | 
| H00563 | Emery-Dreifuss muscular dystrophy | P02545
                            (related) | 
| H00590 | Congenital muscular dystrophies (CMD/MDC) | P02545
                            (related) | 
| H00593 | Limb-girdle muscular dystrophy (LGMD) | P02545
                            (related) | 
| H00601 | Hutchinson-Gilford progeria syndrome | P02545
                            (related) | 
| H00663 | Restrictive dermopathy | P02545
                            (related) | 
| H00665 | Mandibuloacral dysplasia | P02545
                            (related) | 
| H01216 | Left ventricular noncompaction (LVNC) | P02545
                            (related) | 
| H00770 | Congenital myasthenic syndrome | P02708
                            (related) P11230 (related) Q07001 (related) | 
| H00986 | Multiple pterygium syndrome | P02708
                            (related) P07510 (related) Q07001 (related) | 
| H00026 | Endometrial Cancer | P03372
                            (marker) P04626 (related) Q92731 (marker) | 
| H00066 | Lewy body dementia (LBD) | P04062
                            (related) | 
| H00126 | Gaucher disease | P04062
                            (related) | 
| H00426 | Defects in the degradation of ganglioside | P04062
                            (related) | 
| H00810 | Progressive myoclonic epilepsy (PME) | P04062
                            (related) | 
| H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) | P04150
                            (related) | 
| H00019 | Pancreatic cancer | P04626
                            (related) | 
| H00027 | Ovarian cancer | P04626
                            (related) | 
| H00031 | Breast cancer | P04626
                            (related) P04626 (marker) | 
| H00046 | Cholangiocarcinoma | P04626
                            (related) P35354 (related) | 
| H00093 | Combined immunodeficiencies (CIDs) | P06239
                            (related) | 
| H00079 | Asthma | P07550
                            (related) | 
| H00100 | Neutropenic disorders | P08246
                            (related) | 
| H00091 | T-B+Severe combined immunodeficiencies (SCIDs) | P08575
                            (related) | 
| H00036 | Osteosarcoma | P08684
                            (marker) | 
| H00058 | Amyotrophic lateral sclerosis (ALS) | P10636
                            (related) | 
| H00077 | Progressive supranuclear palsy (PSP) | P10636
                            (related) | 
| H00078 | Frontotemporal lobar degeneration (FTLD) | P10636
                            (related) | 
| H01205 | Coumarin resistance | P11712
                            (related) | 
| H00025 | Penile cancer | P14780
                            (related) P35354 (related) | 
| H00479 | Metaphyseal dysplasias | P14780
                            (related) | 
| H00807 | Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) | P17787
                            (related) P43681 (related) Q15822 (related) | 
| H00548 | Brunner syndrome | P21397
                            (related) | 
| H01031 | Orthostatic intolerance (OI) | P23975
                            (related) | 
| H00490 | Diaphyseal dysplasia with anemia (Ghosal) | P24557
                            (related) | 
| H01171 | Poor drug metabolism (PM) | P33261
                            (related) | 
| H00480 | Non-syndromic X-linked mental retardation | P50052
                            (related) Q99714 (related) | 
| H00244 | Pseudohypoparathyroidism | P63092
                            (related) | 
| H00441 | Progressive osseous heteroplasia (POH) | P63092
                            (related) | 
| H00501 | Fibrous dysplasia, polyostotic | P63092
                            (related) | 
| H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) | Q01196
                            (related) Q01196 (marker) Q03164 (related) Q03164 (marker) | 
| H00003 | Acute myeloid leukemia (AML) | Q01196
                            (related) Q01196 (marker) Q13951 (marker) | 
| H00004 | Chronic myeloid leukemia (CML) | Q01196
                            (related) | 
| H00978 | Thrombocytopenia (THC) | Q01196
                            (related) | 
| H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) | Q03164
                            (related) | 
| H00720 | Long QT syndrome | Q12809
                            (related) | 
| H00725 | Short QT syndrome | Q12809
                            (related) | 
| H00658 | Syndromic X-linked mental retardation | Q99714
                            (related) | 
| H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency | Q99714
                            (related) | 
| H00063 | Spinocerebellar ataxia (SCA) | Q9NUW8
                            (related) | 
| MESH or OMIM | name | KNApSAcK metabolite | 
|---|---|---|
| D001145 | Arrhythmias, Cardiac | C00002214 C00002236 | 
| D006331 | Heart Diseases | C00002227 | 
| D064420 | Drug-Related Side Effects and Adverse Reactions | C00002214 | 
| D014693 | Ventricular Fibrillation | C00002214 | 
| D002289 | Carcinoma, Non-Small-Cell Lung | C00002227 | 
| D002779 | Cholestasis | C00002227 | 
| D056487 | Drug-Induced Liver Injury, Chronic | C00002227 | 
| D012640 | Seizures | C00002218 | 
| D008113 | Liver Neoplasms | C00002227 | 
| D003092 | Colitis | C00007758 | 
| D019694 | Hepatitis B, Chronic | C00007758 | 
| D007249 | Inflammation | C00007758 | 
| D008106 | Liver Cirrhosis, Experimental | C00007758 | 
| D054537 | Atrioventricular Block | C00002236 |